Treatment with combination peginterferon alfa-2b and ribavirin of recurrent hepatitis C in liver transplant recipients nonresponsive to interferon alfa-2b and ribavirin

被引：0
|
作者：
Samanta, A
Mandalapu, A
Fisher, A
Wilson, D
de la Torre, A
Klein, KM
Koneru, B
机构：
来源：
GASTROENTEROLOGY | 2005年 / 128卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A455 / A456
页数：2
相关论文
共 50 条
  • [31] Treatment of Recurrent Hepatitis C (Genotype 1) with Pegylated Interferon Alfa-2b and Ribavirin Combination and Maintenance Therapy
    Testino, Gianni
    Sumberaz, Alessandro
    Ansaldi, Filippo
    Borro, Paolo
    Leone, Silvia
    Ancarani, A. Ornella
    Gentile, Raffaella
    Icardi, Giancarlo
    HEPATO-GASTROENTEROLOGY, 2011, 58 (106) : 536 - 538
  • [32] The cost-effectiveness analysis of peginterferon alfa-2a and ribavirin versus interferon alfa-2b and ribavirin in chronic hepatitis C in Poland
    Orlewska, E
    Juszczyk, J
    VALUE IN HEALTH, 2003, 6 (06) : 749 - 750
  • [33] Interim analysis of the safety and efficacy of peginterferon alfa-2a plus ribavirin in chronic hepatitis C patients unable to tolerate or nonresponsive to treatment with peginterferon alfa-2b plus ribavirin
    Rustgi, VK
    Esposito, S
    Freilich, B
    Lopez-Talavera, JC
    Lentz, E
    Shiffman, ML
    HEPATOLOGY, 2005, 42 (04) : 692A - 692A
  • [34] Combination of interferon alfa 2b and ribavirin in liver transplant recipients with histologic recurrent hepatitis C
    Firpi, RJ
    Nelson, DR
    Soldevila, C
    Abdelmalek, MF
    Reed, A
    Hemming, A
    Howard, R
    Van der Werk, W
    Lauwers, G
    Davis, GL
    GASTROENTEROLOGY, 2001, 120 (05) : A93 - A93
  • [35] Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain
    Turnes, Juan
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    Garcia-Samaniego, Javier
    Diago, Moises
    Crespo, Javier
    Calleja, Jose Luis
    Rubio-Terres, Carlos
    Ventayol, Pere
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (09): : 555 - 564
  • [36] Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, J
    Weaver, L
    Schafer, DF
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (08) : 3042 - 3044
  • [37] Cost-utility-analysis of peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin as initial therapy for Chinese naive patients with chronic hepatitis C
    Tarn, YH
    Lin, WA
    VALUE IN HEALTH, 2006, 9 (03) : A46 - A46
  • [38] Combination therapy with interferon alfa-2b, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin
    Pande, H
    Thuluvath, PJ
    Jaffer, SA
    Maygers, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S96 - S96
  • [39] Efficacy of ribavirin monotherapy following combination therapy with interferon alfa-2b and ribavirin for patients with chronic hepatitis C
    Nagayama, A
    Tanaka, A
    Ankoh, H
    Narita, T
    Izumi, M
    Miyake, K
    Takikawa, H
    HEPATOLOGY RESEARCH, 2005, 32 (02) : 101 - 106
  • [40] Interferon ALFA-2B (IFN-a2B)/ribavirin compared to consensus interferon (CIFN)/ribavirin in treatment of chronic hepatitis C
    Sjogren, MH
    Holtzmuller, K
    Sjogren, RW
    JOURNAL OF HEPATOLOGY, 2001, 34 : 234 - 234
12345